Get the newest information about «Health Technology Assessments (HTA)»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)

As soon as new content is published
Daily
Weekly

You will only receive an alert if new information was published since you received one.

[Missing text '/shared/subscription/emailadress' for 'English']

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

Health Technology Assessments (HTA)

Health Technology Assessments (HTA)

The Norwegian Institute of Public Health contributes to national and international Health Technology Assessments.

Les på norsk

HTA for low and middle-income countries

Article

Supporting implementation of HTA in low-and middle-income countries

The Norwegian Institute of Public Health (NIPH) is partnering with low-and middle-income countries to support local implementation of health technology assessments (HTA).

Updated 15.01.2021

Article

Vaccine communication and digital strategies

Governments worldwide are currently planning the rollout of COVID-19 vaccines. Here are three information leaflets for planners and implementers.

Published 21.12.2020

Article

HTA status in the Balkan region

A WHO workshop on HTA in support of universal health coverage in the Balkan region was held in Ljubljana, Slovenia, in February 2020.

Published 23.11.2020

Reports

Health technology assessment

Intracoronary lithotripsy for the treatment of coronary artery disease

We were commissioned to conduct a health technology assessment (HTA) on intracoronary lithotripsy for the treatment of patients with coronary artery disease.

Published 28.09.2020

Health technology assessment

Abdominal aorta aneurysm (AAA) screening of men aged 65

In this HTA we have assessed the clinical effectiveness of screening all 65-years old men for AAA in Norway by updating an earlier HTA report from the Norwegian Institute of Public Health.

Published 25.06.2020

Health technology assessment

Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment

The objective for this health technology assessment was to evaluate clinical efficacy and cost effectiveness for disease-modifying drugs for the treatment of primary progressive multiple sclerosis.

Published 18.02.2020

Health technology assessment

Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment

We were asked to conduct a HTA on "Organ donation using normothermic regional perfusion (NRP) in patients who die of cardiac and respiratory arrest when life-sustaining treatment is withdrawn".

Published 17.12.2019

Health technology assessment

Disease modifying treatments for relapsing remitting multiple sclerosis

This is a health economic evaluation of disease modifying treatments for relapsing remitting multiple sclerosis. We assess the included drugs in light of the Norwegian priority setting criteria.

Published 27.08.2019

Health technology assessment

Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment.

We have systematically collected and reviewed the evidence for clinical effectiveness and general safety issues for disease modifying treatments for relapsing remitting multiple sclerosis.

Published 27.08.2019

Health technology assessment

Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer

We have considered a molecular profiling panel, Prosigna, which is meant to improve the assessment of recurrence risk among women who have undergone surgical treatment for breast cancer.

Published 16.08.2019

Health technology assessment

Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury

What is the clinical effectiveness and safety of prehospital CT for early diagnosis and potential prehospital treatment of suspected acute stroke or severe head injury compared with current practice?

Published 24.06.2019

Health technology assessment

Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk

We were to commissioned perform a HTA evaluating Transcatheter aortic valve implantation (TAVI) as treatment for patients with severe aortic stenosis and intermediate surgical risk.

Published 18.06.2019

Projects

Disinvestment of medical technologies in Specialist Healthcare Services
Safety, clinical effectiveness, diagnostic accuracy and cost effectiveness of blood-based tests for women with suspected pre-eclampsia
Health Technology Assessment of medicines, including rituximab, used for primary progressive multiple sclerosis (PPMS)
Intermittent pneumatic compression to prevent deep vein thrombosis (DVT) in immobile patients with acute stroke
Controlled donation after circulatory death (cDCD) using normothermic regional perfusion in patients who die after withdrawal of life sustaining treatment

See all

Health Technology Assessments (HTA)

HTA for low and middle-income countries

Supporting implementation of HTA in low-and middle-income countries

Vaccine communication and digital strategies

HTA status in the Balkan region

Reports

Intracoronary lithotripsy for the treatment of coronary artery disease

Abdominal aorta aneurysm (AAA) screening of men aged 65

Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment

Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment

Disease modifying treatments for relapsing remitting multiple sclerosis

Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment.

Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer

Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury

Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk

Projects

See also

Systematic reviews

Health service quality measurements

Evidence to Decisions